Allen, C., Sellers, B., Smith, M., Edwards, A., Gateless, K., Aab, B., Sherrard, K., Bolyard, C., & Stover, S
Taken together, these findings suggest that serotonergic hypoactivity alone does not fully account for the complex pathophysiology of MDD
Perturbations of the RhoA-ROCK signaling by intracerebral infusion of the ROCK inhibitor, Y27632, impaired conditioned place aversion (CPA) memory in rats, whereas the infusion of the Rac1 inhibitor, NSC23766, had no effect (Wang et al., 2013)
A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronies disease [retracted in: Safarinejad MR, Asgari MA, Hosseini SY, Dadkhah F